cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Fulgent Genetics Inc
59 own
18 watching
Current Price
$20.36
$0.25
(1.24%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,176.69M
52-Week High
52-Week High
44.09000
52-Week Low
52-Week Low
19.88000
Average Volume
Average Volume
0.15M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
4.8296
iconMarket Capitalization1,176.69M
icon52-Week High44.09000
icon52-Week Low19.88000
iconAverage Volume0.15M
iconDividend Yield--
iconP/E Ratio4.8296
What does the Fulgent Genetics Inc do?
N/A
Read More
How much money does Fulgent Genetics Inc make?
News & Events about Fulgent Genetics Inc.
Business Wire
11 months ago
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced financial results for its first quarter ended March 31, 2023. First Quarter 2023 Results: Total...
Globe Newswire
1 year ago
NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (Scott+Scott), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers of Fulgent Genetics, Inc. (Fulgent) (NASDAQ: FLGT) for ...
Globe Newswire
1 year ago
NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (NASDAQ: FLGT) on behalf of long-term stockholders following a class action complaint that was filed against ...
Globe Newswire
1 year ago
PHILADELPHIA, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine (BR&B) is investigating Fulgent Genetics Inc. based on issues arising from its recent acquisitions, including the acquisition of Fulgent Pharma LLC, a wholly owned subsidiary of Fulgent Pharma Holdings, which itself is wholly-...
Ticker Report
1 year ago
Piper Sandler downgraded shares of Fulgent Genetics (NASDAQ:FLGT Get Rating) from an overweight rating to a neutral rating in a research note issued to investors on Thursday morning, MarketBeat.com reports. They currently have $40.00 price target on the stock, down from their prior price ...
Frequently Asked Questions
Frequently Asked Questions
What is Fulgent Genetics Inc share price today?
plus_minus_icon
Can Indians buy Fulgent Genetics Inc shares?
plus_minus_icon
How can I buy Fulgent Genetics Inc shares from India?
plus_minus_icon
Can Fractional shares of Fulgent Genetics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Fulgent Genetics Inc stocks?
plus_minus_icon
What is today’s traded volume of Fulgent Genetics Inc?
plus_minus_icon
What is today’s market capitalisation of Fulgent Genetics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Fulgent Genetics Inc?
plus_minus_icon
What percentage is Fulgent Genetics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Fulgent Genetics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$20.36
$0.25
(1.24%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00